Clinical trials recruiting for Tauopathies
4
Recruiting trials
4
US states with sites
3
Countries
50%
Accept healthy volunteers
Phase breakdown
Early Phase 1 2Not applicable 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| 11C-M503 PET | 1 |
| 18F-JSS20-183A PET | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Pennsylvania | 2 |
| California | 1 |
| Connecticut | 1 |
| Missouri | 1 |
Top cities
Self-screener
Recruiting trials
- Neurodegenerative Diseases Progression Markers (MARKERS-NDD)
- Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A
- Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503
- [18F]NIDF PET Imaging in Tau-related Diseases
Related conditions
Trials recruiting for Tauopathies often also study these conditions. Each links to its own recruiting-trial list.
Alzheimer's disease 617Synucleinopathies 8Parkinson's disease 522Neurodegenerative Diseases 23Neurodegenerative Disease 4Multiple System Atrophy 15Multiple sclerosis 445Movement Disorders 12Lewy Body Disease 13Frontotemporal Lobar Degeneration 3
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Tauopathies trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.